Article
[Methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes].
Polskie Archiwum Medycyny Wewnetrznej - 1 Jul 2001
Dzida G, Biłan A, Golon-Siekierska P, Strzemecka J, Sobstyl J, Puźniak A, Mosiewicz J, Hanzlik J
Abstract excerpt
Hyperhomocysteinemia is recognised as a risk factor of ischaemic heart disease and vascular complications of arterial hypertension. Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism is associated with hyperhomocysteinaemia. The aim of the study was the assessment of an association of the above polymorphism with type 2 diabetes with special attention to myocardial infarction and arterial...
Topics
- Aged
- Case-Control Studies
- Diabetes Mellitus, Type 2
- Female
- Genotype
- Humans
- Hyperhomocysteinemia
- Hypertension
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
- Middle Aged
